Search results
Results from the WOW.Com Content Network
In addition to helping people with diabetes manage their blood sugar levels, this GLP-1 (glucagon-like peptide 1 receptor agonist) medication helps reduce appetite and curb food cravings ...
GLP-1 Diet Plan. GLP-1 medications — that’s glucagon-like peptide-1 receptor agonists — are prescribed alongside diet and exercise to help people lose weight or manage type 2 diabetes. But ...
Drugs like Ozempic, Wegovy and newly-approved Zepbound have become part of the public lexicon in 2023. Though Ozempic is FDA-approved for diabetes management, Wegovy and Zepbound are sought-after ...
In Subsaharan Africa, diabetes patients face social stigma from family and community members from diabetes and diabetes-related self-management requirements which prevent diabetes-related self-care. [28] A study found that when there is diabetes that runs in the family, it becomes a family affair and participants normalise and downplay the ...
Prevention of type 2 diabetes can be achieved with both lifestyle changes and use of medication. [1] The American Diabetes Association categorizes people with prediabetes, who have glycemic levels higher than normal but do not meet criteria for diabetes, as a high-risk group. Without intervention, people with prediabetes progress to type 2 ...
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of the human body , weight regulation, by: reducing appetite and consequently energy intake , increasing energy expenditure , redirecting nutrients from adipose to lean ...
Quick refresher: Wegovy is approved by the Food and Drug Administration for chronic weight management in adults with either obesity (body mass index, or BMI, of 30+) or overweight (BMI of 27 ...
A large study of more than 2 million people evaluated GLP-1 agonists' benefits and risks. The study showed that GLP-1 agonists reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimer’s disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses, and several respiratory conditions. [5]